Prognostic Role of Pathological Complete Response in Early Stage Epithelial Solid Tumors.

Cancer Control · 2023 · PMC10126800 · PMID 37073789

Europe PMC DOI

hedged sentence

0.0570

closest p · 1.1× alpha

0.0570

boldest claim

The sentences

did not reach statistical significanceP = .057so close (0.05 < p ≤ 0.1)

Results showed that, thanks to carboplatin administration, the pCR rates improved from 41% to 54% (OR = 1.71; P = .0029), while the bevacizumab treatment improved pCR rate (52% vs 44%) but the results did not reach statistical significance (OR = 1.36; P = .057).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.